Study participants were randomly assigned 2:1 to receive oral semaglutide 25mg (n=205) or placebo (n=102), as an adjunct to lifestyle intervention. The coprimary endpoints were the relative change in ...

The risk for ocular problems linked to different formulations of semaglutide appear to vary, according to a new study, which ...

Half of the participants took a semaglutide tablet daily and half took a placebo. Participants continued their assigned regimen for an average of just under four years. By the end of the trial ...

(Reuters) -(To receive the full newsletter in your inbox for free sign up here) Novo Nordisk’s diabetes medicine Rybelsus, an oral form of the GLP-1 drug semaglutide, provides similar ...

Another effect that Rybelsus has is that it can promote weight loss via appetite control. Although not approved for weight loss, this semaglutide tablet is often prescribed off label by healthcare ...

Using real-world data from over 300,000 cases, scientists uncovered a significant link between semaglutide and reported vision problems—raising new concerns about the safety profile of this ...

More information: Meghan I. Podolsky et al, Factors Associated With Semaglutide Initiation Among Adults With Obesity, JAMA Network Open (2025). DOI: 10.1001/jamanetworkopen.2024.55222 Provided by ...

The proprietary Self-Emulsifying Drug Delivery System (SEDDS) formulation in form of orally dispersible films allows absorption of sublingually administrated peptides such as GLP-1 (Semaglutide ...